Cargando…

Antibody-Directed Glucocorticoid Targeting to CD163 in M2-type Macrophages Attenuates Fructose-Induced Liver Inflammatory Changes

Increased consumption of high-caloric carbohydrates contributes substantially to endemic non-alcoholic fatty liver disease in humans, covering a histological spectrum from fatty liver to steatohepatitis. Hypercaloric intake and lipogenetic effects of fructose and endotoxin-driven activation of liver...

Descripción completa

Detalles Bibliográficos
Autores principales:	Svendsen, Pia, Graversen, Jonas H., Etzerodt, Anders, Hager, Henrik, Røge, Rasmus, Grønbæk, Henning, Christensen, Erik I., Møller, Holger J., Vilstrup, Hendrik, Moestrup, Søren K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363319/ https://www.ncbi.nlm.nih.gov/pubmed/28344991 http://dx.doi.org/10.1016/j.omtm.2016.11.004

Ejemplares similares

Targeting the Hemoglobin Scavenger receptor CD163 in Macrophages Highly Increases the Anti-inflammatory Potency of Dexamethasone
por: Graversen, Jonas H, et al.
Publicado: (2012)

The Haptoglobin-CD163-Heme Oxygenase-1 Pathway for Hemoglobin Scavenging
por: Thomsen, Jens Haugbølle, et al.
Publicado: (2013)

Mouse CD163 deficiency strongly enhances experimental collagen-induced arthritis
por: Svendsen, Pia, et al.
Publicado: (2020)

Drug Trafficking into Macrophages via the Endocytotic Receptor CD163
por: Graversen, Jonas Heilskov, et al.
Publicado: (2015)

Soluble ectodomain CD163 and extracellular vesicle-associated CD163 are two differently regulated forms of ‘soluble CD163’ in plasma
por: Etzerodt, Anders, et al.
Publicado: (2017)

Targeting of CD163(+) Macrophages in Inflammatory and Malignant Diseases
por: Skytthe, Maria K., et al.
Publicado: (2020)

Anti-CD163-dexamethasone protects against apoptosis after ischemia/reperfusion injuries in the rat liver
por: Møller, Lin Nanna Okholm, et al.
Publicado: (2015)

Targeted lipid nanoparticle delivery of calcitriol to human monocyte-derived macrophages in vitro and in vivo: investigation of the anti-inflammatory effects of calcitriol
por: Rafique, Aisha, et al.
Publicado: (2019)

Specific targeting of CD163(+) TAMs mobilizes inflammatory monocytes and promotes T cell–mediated tumor regression
por: Etzerodt, Anders, et al.
Publicado: (2019)

Anti-inflammatory liposomes have no impact on liver regeneration in rats
por: Jepsen, Betina Norman, et al.
Publicado: (2015)

Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure
por: Nielsen, Marlene Christina, et al.
Publicado: (2020)

Soluble CD163 Changes Indicate Monocyte Association With Cognitive Deficits in Parkinson's Disease
por: Nissen, Sara Konstantin, et al.
Publicado: (2020)

Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis
por: Gantzel, Rasmus Hvidbjerg, et al.
Publicado: (2021)

High-fructose feeding does not induce steatosis or non-alcoholic fatty liver disease in pigs
por: Schmidt, Nikolaj H., et al.
Publicado: (2021)

Soluble CD163 correlates with lipid metabolic adaptations in type 1 diabetes patients during ketoacidosis
por: Svart, Mads, et al.
Publicado: (2018)

The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson’s disease
por: Glavind, Emilie, et al.
Publicado: (2020)

Macrophage activation marker sCD163 correlates with accelerated lipolysis following LPS exposure: a human-randomised clinical trial
por: Rittig, Nikolaj, et al.
Publicado: (2017)

Soluble haemoglobin scavenger receptor (sCD163): a marker associated with bacteraemia
por: Gaïni, S, et al.
Publicado: (2005)

Local production of soluble CD163 in the spondyloarthropathic joint
por: Baeten, D, et al.
Publicado: (2003)

Macrophage activation marker sCD163 is associated with liver injury and hepatic insulin resistance in obese patients before and after Roux‐en‐Y gastric bypass
por: Kazankov, Konstantin, et al.
Publicado: (2022)

The soluble mannose receptor (sMR) is elevated in alcoholic liver disease and associated with disease severity, portal hypertension, and mortality in cirrhosis patients
por: Sandahl, Thomas Damgaard, et al.
Publicado: (2017)

Divergences in Macrophage Activation Markers Soluble CD163 and Mannose Receptor in Patients With Non-cirrhotic and Cirrhotic Portal Hypertension
por: Ørntoft, Nikolaj Worm, et al.
Publicado: (2021)

Liver cirrhosis, other liver diseases, and risk of hospitalisation for intracerebral haemorrhage: A Danish population-based case-control study
por: Grønbæk, Henning, et al.
Publicado: (2008)

High hepatic macrophage activation and low liver function in stable Wilson patients - a Danish cross-sectional study
por: Björklund, Jessica, et al.
Publicado: (2018)

No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial
por: Kimer, Nina, et al.
Publicado: (2018)

Development and validation of the Cirrhotic Ascites Severity model—A patient‐reported outcome‐based model to predict 1‐year mortality
por: Gantzel, Rasmus Hvidbjerg, et al.
Publicado: (2022)

Alcoholic Hepatitis Markedly Decreases the Capacity for Urea Synthesis
por: Glavind, Emilie, et al.
Publicado: (2016)

Effects of glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, on markers of liver status in patients with short bowel syndrome: findings from a randomised phase 2 trial
por: Naimi, Rahim Mohammad, et al.
Publicado: (2019)

The association between soluble CD163, disease severity, and ursodiol treatment in patients with primary biliary cholangitis
por: Bossen, Lars, et al.
Publicado: (2023)

Structural assembly of the megadalton-sized receptor for intestinal vitamin B(12) uptake and kidney protein reabsorption
por: Larsen, Casper, et al.
Publicado: (2018)

Portal vein thrombosis; risk factors, clinical presentation and treatment
por: Sogaard, Kirstine K, et al.
Publicado: (2007)

Monocyte Expression and Soluble Levels of the Haemoglobin Receptor (CD163/sCD163) and the Mannose Receptor (MR/sMR) in Septic and Critically Ill Non-Septic ICU Patients
por: Kjærgaard, Anders G., et al.
Publicado: (2014)

Effects of urodilatin on natriuresis in cirrhosis patients with sodium retention
por: Carstens, Jan, et al.
Publicado: (2007)

The macrophage low-grade inflammation marker sCD163 is modulated by exogenous sex steroids
por: Thomsen, Henrik H, et al.
Publicado: (2013)

Isolated congenital hepatic fibrosis associated with TMEM67 mutations: report of a new genotype–phenotype relationship
por: Vogel, Ida, et al.
Publicado: (2017)

Fructose, Glucocorticoids and Adipose Tissue: Implications for the Metabolic Syndrome
por: Legeza, Balázs, et al.
Publicado: (2017)

Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients with Multiple Sclerosis
por: Stilund, Morten, et al.
Publicado: (2014)

Invasive margin tissue-resident macrophages of high CD163 expression impede responses to T cell-based immunotherapy
por: van Elsas, Marit J, et al.
Publicado: (2023)

Visceral obesity is associated with increased soluble CD163 concentration in men with type 2 diabetes mellitus
por: Sørensen, Lars Peter, et al.
Publicado: (2015)

Highest Frequencies of Interleukin-22-Producing T Helper Cells in Alcoholic Hepatitis Patients with a Favourable Short-Term Course
por: Støy, Sidsel, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_51avesiflr61jtoui619fhc7pf